House, Senate Appropriators Set FDA Spending Below White House Request
This article was originally published in The Tan Sheet
Executive Summary
Both the House and Senate Appropriations subcommittee set agency funding about $300 million less than President Obama requested. The Senate bill adds $1.5 million to the Health and Human Services Department Office of Inspector General specifically for FDA oversight activities.
You may also be interested in...
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.
Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director
Nicole Verdun said children could participate in gene therapy clinical trials earlier if the necessary controls are in place.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.